SCANPHARM A/S — Credit Rating and Financial Key Figures
CVR number: 16279099
Topstykket 12, 3460 Birkerød
tel: 45826046
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 5 118.41 | 11 259.43 | 17 399.14 | 22 519.43 | 26 903.80 |
Employee benefit expenses | -19 391.00 | -18 905.94 | -21 127.92 | -24 334.74 | -23 961.64 |
Other operating expenses | - 334.46 | - 334.46 | |||
Total depreciation | -1 823.49 | -1 737.32 | -1 810.61 | -1 717.31 | -1 262.68 |
EBIT | -16 096.07 | -9 718.29 | -5 204.94 | -3 532.62 | 1 679.48 |
Other financial income | 33.11 | ||||
Other financial expenses | -1 035.88 | -1 305.70 | -1 407.55 | - 986.17 | -1 135.25 |
Pre-tax profit | -17 098.85 | -10 784.66 | -6 105.89 | -4 424.69 | 582.68 |
Income taxes | -1 842.45 | -85.92 | 151.43 | ||
Net earnings | -18 941.30 | -10 870.59 | -5 954.45 | -4 424.69 | 582.68 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Goodwill | 392.97 | 283.78 | 137.58 | 41.08 | |
Intangible assets total | 392.97 | 283.78 | 137.58 | 41.08 | |
Buildings | 14 637.45 | 13 673.97 | 13 081.61 | 13 724.56 | 16 364.74 |
Machinery and equipment | 436.53 | 359.40 | 313.60 | 275.59 | 240.31 |
Tangible assets total | 15 073.98 | 14 033.38 | 13 395.21 | 14 000.15 | 16 605.05 |
Investments total | |||||
Long term receivables total | |||||
Raw materials and consumables | 2 992.71 | 2 725.76 | 5 840.96 | 8 317.13 | 4 029.04 |
Finished products/goods | 3 309.88 | 2 502.80 | 717.12 | 880.75 | 1 365.40 |
Advance payments | 551.51 | ||||
Inventories total | 6 302.59 | 5 228.56 | 6 558.08 | 9 749.40 | 5 394.44 |
Current other receivables | 9 640.47 | 8 636.88 | 8 688.14 | 6 930.89 | 12 188.84 |
Current deferred tax assets | 814.49 | 728.57 | 880.00 | 880.00 | 880.00 |
Short term receivables total | 10 454.96 | 9 365.45 | 9 568.14 | 7 810.89 | 13 068.84 |
Balance sheet total (assets) | 32 224.49 | 28 911.17 | 29 659.02 | 31 601.52 | 35 068.32 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 3 000.00 | 3 000.00 | 3 000.00 | 3 000.00 | 3 000.00 |
Asset revaluation reserve | 1 488.24 | 1 424.59 | 1 360.94 | 1 297.30 | 1 233.65 |
Retained earnings | 16 366.20 | 7 945.99 | 3 093.51 | 1 627.39 | -2 733.65 |
Profit of the financial year | -18 941.30 | -10 870.59 | -5 954.45 | -4 424.69 | 582.68 |
Shareholders equity total | 1 913.14 | 1 500.00 | 1 500.00 | 1 500.00 | 2 082.68 |
Non-current leasing loans | 3 600.93 | 2 408.89 | 1 478.59 | 2 264.21 | 1 735.12 |
Non-current other liabilities | 1 579.82 | 1 537.00 | 1 428.65 | 1 361.09 | 1 403.28 |
Non-current liabilities total | 5 180.76 | 3 945.89 | 2 907.24 | 3 625.29 | 3 138.40 |
Current loans from credit institutions | 13 773.65 | 12 360.79 | 8 094.00 | 9 976.21 | 9 006.27 |
Advances received | 129.95 | 348.62 | 1 119.10 | 4 313.31 | |
Current trade creditors | 7 652.35 | 4 738.44 | 3 763.81 | 4 253.34 | 3 024.15 |
Current owed to group member | 4 182.55 | 9 154.23 | 7 967.04 | 10 993.91 | |
Other non-interest bearing current liabilities | 3 574.66 | 1 834.89 | 3 120.63 | 4 279.64 | 2 509.60 |
Current liabilities total | 25 130.60 | 23 465.28 | 25 251.78 | 26 476.22 | 29 847.24 |
Balance sheet total (liabilities) | 32 224.49 | 28 911.17 | 29 659.02 | 31 601.52 | 35 068.32 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.